Used in pharmaceutical research as a key intermediate in the synthesis of bioactive molecules, particularly in the development of central nervous system agents. Its structure supports binding to neurological receptors, making it valuable in creating potential treatments for psychiatric and neurological disorders. The compound's piperidine-pyrazine framework is often explored in drug discovery for its favorable pharmacokinetic properties and ability to cross the blood-brain barrier. It is also employed in the design of selective enzyme inhibitors and receptor modulators due to its adaptable molecular geometry and hydrogen bonding capacity.